For knee, ayurveda found as good as high-end drugs
- Supreme Court curtails BCCI's financial powers, independent auditor to scrutinise accounts
- Bhubaneswar hospital fire: More patients succumb to injuries, death toll reaches 24
- Embraer aircraft deal: CBI names defence agent Vipin Khanna as key beneficiary in payoffs FIR
- Scrap English requirement, references that insult India: RSS edu wing to HRD
- US: 500 million pages of sensitive govt record stolen by ex-NSA contractor
An Ayurvedic preparation has passed a test as an alternative to high-end drugs for the treatment of knee osteoarthritis. And it has shown few adverse effects, according to the study, which involved government-supported clinical trials across the country. The trials were held in 2006-07 and the findings have been published now in the British journal Rheumatology.
Dr R A Mashelkar, former director-general of the Council of Scientific and Industrial Research, who has for two decades striven to get diverse medical disciplines together, told The Indian Express that the endorsement by a reputable medical journal shows that the research is a credible one.
The drugs commonly used for knee osteoarthritis are the high-end glucosamine sulphate and celecoxib. According to experts, patients may deteriorate to end-stage arthritis and require joint replacement surgery, which is expensive and not universally accessible. Osteoarthritis is also predominantly treated with analgesics, which provide symptomatic, long-term pain relief but also expose patients to potentially serious toxicity.
In a first, scientists made a head-to-head comparison. They chose ayurvedic formulations based on texts and expert opinion. They found that two shunthi-guduchi formulations, called SGC and SGCG, were equivalent to oral glucosamine sulphate and celecoxib in reducing knee pain and improving knee function in patients.
The trials were carried out over 24 weeks in 2006-07 at New Delhi's AIIMS, Hyderabad's Nizam Institute of Medical Sciences and Pune's Centre for Rheumatic Diseases, says the study's coordinator, Dr Arvind Chopra, director of the Pune-based CRD.
On 440 osteoarthritis patients aged between 40 and 70, scientists evaluated the effects of ayurvedic formulations against those of glucosamine sulphate (2 gm daily) and celecoxib (200 mg daily). The ayurvedic formulations significantly reduced knee pain and improved knee function. Of the patients, 26 showed an asymptomatic increase in an enzyme called SGPT, with otherwise normal liver function. Seven patients on Ayurvedic intervention were withdrawn and the SGPT went back to normal. Other adverse events were mild, scientists said.
- Khurram Parvez jailing appears unjust, against govt’s self-interest in troubled Kashmir
- Under PM Modi, new synergy between India’s economic & foreign policy
- Climate justice must be ingrained in rules of new climate compacts
- Despite his outrageous views, Donald Trump represents hope to many Americans
- One advantage of redefining military action as surgery is that it mobilises rhetoric of health
- SC stand on triple talaq remains to be seen